img

Global Macrolide Drugs Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Macrolide Drugs Market Research Report 2024

The macrolide drugs are a group of antibiotics produced by various strains of Streptomyces (spore forming bacteria that grow slowly in soil or water as a branching filamentous mycelium similar to that of fungi) and have a complex chemical (macrocyclic) structure. They act by inhibiting protein synthesis, specifically by blocking the 50S ribosomal subunit. They are broad spectrum antibiotics.
According to Mr Accuracy reports’s new survey, global Macrolide Drugs market is projected to reach US$ million in 2034, increasing from US$ million in 2024, with the CAGR of % during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Macrolide Drugs market research.
Key manufacturers engaged in the Macrolide Drugs industry include Abbott Laboratories, Akorn, Eli Lilly & Co., Fresenius Kabi, Gland Pharmm, Sirolimus, Neo Química, Tacorolimus and Macrolide Pharmaceuticals, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2024.
When refers to consumption region, % volume of Macrolide Drugs were sold to North America, Europe and Asia Pacific in 2024. Moreover, China, plays a key role in the whole Macrolide Drugs market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Macrolide Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Abbott Laboratories
Akorn
Eli Lilly & Co.
Fresenius Kabi
Gland Pharmm
Sirolimus
Neo Química
Tacorolimus
Macrolide Pharmaceuticals
Mylan
Pfizer
Sanofi
Merck & Co.
Sandoz International
Teva Pharmaceutical Industries
WOCKHARDT
Segment by Type
14-Membered Ring Agents
15-Membered Ring Agents
16-Membered Ring Agents
Ketolides

Segment by Application


Hospitals
Clinics
Hospitalshospital Pharmacies
Retail Pharmacies
Online Pharmacies

Consumption by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Macrolide Drugs report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Macrolide Drugs Market Overview
1.1 Product Overview and Scope of Macrolide Drugs
1.2 Macrolide Drugs Segment by Type
1.2.1 Global Macrolide Drugs Market Value Comparison by Type (2024-2034)
1.2.2 14-Membered Ring Agents
1.2.3 15-Membered Ring Agents
1.2.4 16-Membered Ring Agents
1.2.5 Ketolides
1.3 Macrolide Drugs Segment by Application
1.3.1 Global Macrolide Drugs Market Value by Application: (2024-2034)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Hospitalshospital Pharmacies
1.3.5 Retail Pharmacies
1.3.6 Online Pharmacies
1.4 Global Macrolide Drugs Market Size Estimates and Forecasts
1.4.1 Global Macrolide Drugs Revenue 2018-2034
1.4.2 Global Macrolide Drugs Sales 2018-2034
1.4.3 Global Macrolide Drugs Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Macrolide Drugs Market Competition by Manufacturers
2.1 Global Macrolide Drugs Sales Market Share by Manufacturers (2018-2023)
2.2 Global Macrolide Drugs Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Macrolide Drugs Average Price by Manufacturers (2018-2023)
2.4 Global Macrolide Drugs Industry Ranking 2021 VS 2024 VS 2023
2.5 Global Key Manufacturers of Macrolide Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Macrolide Drugs, Product Type & Application
2.7 Macrolide Drugs Market Competitive Situation and Trends
2.7.1 Macrolide Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Macrolide Drugs Players Market Share by Revenue
2.7.3 Global Macrolide Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Macrolide Drugs Retrospective Market Scenario by Region
3.1 Global Macrolide Drugs Market Size by Region: 2018 Versus 2024 Versus 2034
3.2 Global Macrolide Drugs Global Macrolide Drugs Sales by Region: 2018-2034
3.2.1 Global Macrolide Drugs Sales by Region: 2018-2023
3.2.2 Global Macrolide Drugs Sales by Region: 2024-2034
3.3 Global Macrolide Drugs Global Macrolide Drugs Revenue by Region: 2018-2034
3.3.1 Global Macrolide Drugs Revenue by Region: 2018-2023
3.3.2 Global Macrolide Drugs Revenue by Region: 2024-2034
3.4 North America Macrolide Drugs Market Facts & Figures by Country
3.4.1 North America Macrolide Drugs Market Size by Country: 2018 VS 2024 VS 2034
3.4.2 North America Macrolide Drugs Sales by Country (2018-2034)
3.4.3 North America Macrolide Drugs Revenue by Country (2018-2034)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Macrolide Drugs Market Facts & Figures by Country
3.5.1 Europe Macrolide Drugs Market Size by Country: 2018 VS 2024 VS 2034
3.5.2 Europe Macrolide Drugs Sales by Country (2018-2034)
3.5.3 Europe Macrolide Drugs Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Macrolide Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Macrolide Drugs Market Size by Country: 2018 VS 2024 VS 2034
3.6.2 Asia Pacific Macrolide Drugs Sales by Country (2018-2034)
3.6.3 Asia Pacific Macrolide Drugs Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Macrolide Drugs Market Facts & Figures by Country
3.7.1 Latin America Macrolide Drugs Market Size by Country: 2018 VS 2024 VS 2034
3.7.2 Latin America Macrolide Drugs Sales by Country (2018-2034)
3.7.3 Latin America Macrolide Drugs Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Macrolide Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Macrolide Drugs Market Size by Country: 2018 VS 2024 VS 2034
3.8.2 Middle East and Africa Macrolide Drugs Sales by Country (2018-2034)
3.8.3 Middle East and Africa Macrolide Drugs Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Macrolide Drugs Sales by Type (2018-2034)
4.1.1 Global Macrolide Drugs Sales by Type (2018-2023)
4.1.2 Global Macrolide Drugs Sales by Type (2024-2034)
4.1.3 Global Macrolide Drugs Sales Market Share by Type (2018-2034)
4.2 Global Macrolide Drugs Revenue by Type (2018-2034)
4.2.1 Global Macrolide Drugs Revenue by Type (2018-2023)
4.2.2 Global Macrolide Drugs Revenue by Type (2024-2034)
4.2.3 Global Macrolide Drugs Revenue Market Share by Type (2018-2034)
4.3 Global Macrolide Drugs Price by Type (2018-2034)
5 Segment by Application
5.1 Global Macrolide Drugs Sales by Application (2018-2034)
5.1.1 Global Macrolide Drugs Sales by Application (2018-2023)
5.1.2 Global Macrolide Drugs Sales by Application (2024-2034)
5.1.3 Global Macrolide Drugs Sales Market Share by Application (2018-2034)
5.2 Global Macrolide Drugs Revenue by Application (2018-2034)
5.2.1 Global Macrolide Drugs Revenue by Application (2018-2023)
5.2.2 Global Macrolide Drugs Revenue by Application (2024-2034)
5.2.3 Global Macrolide Drugs Revenue Market Share by Application (2018-2034)
5.3 Global Macrolide Drugs Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Abbott Laboratories
6.1.1 Abbott Laboratories Corporation Information
6.1.2 Abbott Laboratories Description and Business Overview
6.1.3 Abbott Laboratories Macrolide Drugs Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Abbott Laboratories Macrolide Drugs Product Portfolio
6.1.5 Abbott Laboratories Recent Developments/Updates
6.2 Akorn
6.2.1 Akorn Corporation Information
6.2.2 Akorn Description and Business Overview
6.2.3 Akorn Macrolide Drugs Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Akorn Macrolide Drugs Product Portfolio
6.2.5 Akorn Recent Developments/Updates
6.3 Eli Lilly & Co.
6.3.1 Eli Lilly & Co. Corporation Information
6.3.2 Eli Lilly & Co. Description and Business Overview
6.3.3 Eli Lilly & Co. Macrolide Drugs Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Eli Lilly & Co. Macrolide Drugs Product Portfolio
6.3.5 Eli Lilly & Co. Recent Developments/Updates
6.4 Fresenius Kabi
6.4.1 Fresenius Kabi Corporation Information
6.4.2 Fresenius Kabi Description and Business Overview
6.4.3 Fresenius Kabi Macrolide Drugs Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Fresenius Kabi Macrolide Drugs Product Portfolio
6.4.5 Fresenius Kabi Recent Developments/Updates
6.5 Gland Pharmm
6.5.1 Gland Pharmm Corporation Information
6.5.2 Gland Pharmm Description and Business Overview
6.5.3 Gland Pharmm Macrolide Drugs Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Gland Pharmm Macrolide Drugs Product Portfolio
6.5.5 Gland Pharmm Recent Developments/Updates
6.6 Sirolimus
6.6.1 Sirolimus Corporation Information
6.6.2 Sirolimus Description and Business Overview
6.6.3 Sirolimus Macrolide Drugs Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Sirolimus Macrolide Drugs Product Portfolio
6.6.5 Sirolimus Recent Developments/Updates
6.7 Neo Química
6.6.1 Neo Química Corporation Information
6.6.2 Neo Química Description and Business Overview
6.6.3 Neo Química Macrolide Drugs Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Neo Química Macrolide Drugs Product Portfolio
6.7.5 Neo Química Recent Developments/Updates
6.8 Tacorolimus
6.8.1 Tacorolimus Corporation Information
6.8.2 Tacorolimus Description and Business Overview
6.8.3 Tacorolimus Macrolide Drugs Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Tacorolimus Macrolide Drugs Product Portfolio
6.8.5 Tacorolimus Recent Developments/Updates
6.9 Macrolide Pharmaceuticals
6.9.1 Macrolide Pharmaceuticals Corporation Information
6.9.2 Macrolide Pharmaceuticals Description and Business Overview
6.9.3 Macrolide Pharmaceuticals Macrolide Drugs Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Macrolide Pharmaceuticals Macrolide Drugs Product Portfolio
6.9.5 Macrolide Pharmaceuticals Recent Developments/Updates
6.10 Mylan
6.10.1 Mylan Corporation Information
6.10.2 Mylan Description and Business Overview
6.10.3 Mylan Macrolide Drugs Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Mylan Macrolide Drugs Product Portfolio
6.10.5 Mylan Recent Developments/Updates
6.11 Pfizer
6.11.1 Pfizer Corporation Information
6.11.2 Pfizer Macrolide Drugs Description and Business Overview
6.11.3 Pfizer Macrolide Drugs Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Pfizer Macrolide Drugs Product Portfolio
6.11.5 Pfizer Recent Developments/Updates
6.12 Sanofi
6.12.1 Sanofi Corporation Information
6.12.2 Sanofi Macrolide Drugs Description and Business Overview
6.12.3 Sanofi Macrolide Drugs Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Sanofi Macrolide Drugs Product Portfolio
6.12.5 Sanofi Recent Developments/Updates
6.13 Merck & Co.
6.13.1 Merck & Co. Corporation Information
6.13.2 Merck & Co. Macrolide Drugs Description and Business Overview
6.13.3 Merck & Co. Macrolide Drugs Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Merck & Co. Macrolide Drugs Product Portfolio
6.13.5 Merck & Co. Recent Developments/Updates
6.14 Sandoz International
6.14.1 Sandoz International Corporation Information
6.14.2 Sandoz International Macrolide Drugs Description and Business Overview
6.14.3 Sandoz International Macrolide Drugs Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Sandoz International Macrolide Drugs Product Portfolio
6.14.5 Sandoz International Recent Developments/Updates
6.15 Teva Pharmaceutical Industries
6.15.1 Teva Pharmaceutical Industries Corporation Information
6.15.2 Teva Pharmaceutical Industries Macrolide Drugs Description and Business Overview
6.15.3 Teva Pharmaceutical Industries Macrolide Drugs Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Teva Pharmaceutical Industries Macrolide Drugs Product Portfolio
6.15.5 Teva Pharmaceutical Industries Recent Developments/Updates
6.16 WOCKHARDT
6.16.1 WOCKHARDT Corporation Information
6.16.2 WOCKHARDT Macrolide Drugs Description and Business Overview
6.16.3 WOCKHARDT Macrolide Drugs Sales, Revenue and Gross Margin (2018-2023)
6.16.4 WOCKHARDT Macrolide Drugs Product Portfolio
6.16.5 WOCKHARDT Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Macrolide Drugs Industry Chain Analysis
7.2 Macrolide Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Macrolide Drugs Production Mode & Process
7.4 Macrolide Drugs Sales and Marketing
7.4.1 Macrolide Drugs Sales Channels
7.4.2 Macrolide Drugs Distributors
7.5 Macrolide Drugs Customers
8 Macrolide Drugs Market Dynamics
8.1 Macrolide Drugs Industry Trends
8.2 Macrolide Drugs Market Drivers
8.3 Macrolide Drugs Market Challenges
8.4 Macrolide Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Macrolide Drugs Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Macrolide Drugs Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Macrolide Drugs Market Competitive Situation by Manufacturers in 2024
Table 4. Global Macrolide Drugs Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Macrolide Drugs Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Macrolide Drugs Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Macrolide Drugs Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Macrolide Drugs Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Macrolide Drugs, Industry Ranking, 2021 VS 2024 VS 2023
Table 10. Global Key Manufacturers of Macrolide Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Macrolide Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Macrolide Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Macrolide Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Macrolide Drugs as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Macrolide Drugs Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 17. Global Macrolide Drugs Sales by Region (2018-2023) & (K Units)
Table 18. Global Macrolide Drugs Sales Market Share by Region (2018-2023)
Table 19. Global Macrolide Drugs Sales by Region (2024-2034) & (K Units)
Table 20. Global Macrolide Drugs Sales Market Share by Region (2024-2034)
Table 21. Global Macrolide Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Macrolide Drugs Revenue Market Share by Region (2018-2023)
Table 23. Global Macrolide Drugs Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Macrolide Drugs Revenue Market Share by Region (2024-2034)
Table 25. North America Macrolide Drugs Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 26. North America Macrolide Drugs Sales by Country (2018-2023) & (K Units)
Table 27. North America Macrolide Drugs Sales by Country (2024-2034) & (K Units)
Table 28. North America Macrolide Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Macrolide Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Macrolide Drugs Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 31. Europe Macrolide Drugs Sales by Country (2018-2023) & (K Units)
Table 32. Europe Macrolide Drugs Sales by Country (2024-2034) & (K Units)
Table 33. Europe Macrolide Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Macrolide Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Macrolide Drugs Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 36. Asia Pacific Macrolide Drugs Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Macrolide Drugs Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Macrolide Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Macrolide Drugs Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Macrolide Drugs Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 41. Latin America Macrolide Drugs Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Macrolide Drugs Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Macrolide Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Macrolide Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Macrolide Drugs Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 46. Middle East & Africa Macrolide Drugs Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Macrolide Drugs Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Macrolide Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Macrolide Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Macrolide Drugs Sales (K Units) by Type (2018-2023)
Table 51. Global Macrolide Drugs Sales (K Units) by Type (2024-2034)
Table 52. Global Macrolide Drugs Sales Market Share by Type (2018-2023)
Table 53. Global Macrolide Drugs Sales Market Share by Type (2024-2034)
Table 54. Global Macrolide Drugs Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Macrolide Drugs Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Macrolide Drugs Revenue Market Share by Type (2018-2023)
Table 57. Global Macrolide Drugs Revenue Market Share by Type (2024-2034)
Table 58. Global Macrolide Drugs Price (USD/Unit) by Type (2018-2023)
Table 59. Global Macrolide Drugs Price (USD/Unit) by Type (2024-2034)
Table 60. Global Macrolide Drugs Sales (K Units) by Application (2018-2023)
Table 61. Global Macrolide Drugs Sales (K Units) by Application (2024-2034)
Table 62. Global Macrolide Drugs Sales Market Share by Application (2018-2023)
Table 63. Global Macrolide Drugs Sales Market Share by Application (2024-2034)
Table 64. Global Macrolide Drugs Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Macrolide Drugs Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Macrolide Drugs Revenue Market Share by Application (2018-2023)
Table 67. Global Macrolide Drugs Revenue Market Share by Application (2024-2034)
Table 68. Global Macrolide Drugs Price (USD/Unit) by Application (2018-2023)
Table 69. Global Macrolide Drugs Price (USD/Unit) by Application (2024-2034)
Table 70. Abbott Laboratories Corporation Information
Table 71. Abbott Laboratories Description and Business Overview
Table 72. Abbott Laboratories Macrolide Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 73. Abbott Laboratories Macrolide Drugs Product
Table 74. Abbott Laboratories Recent Developments/Updates
Table 75. Akorn Corporation Information
Table 76. Akorn Description and Business Overview
Table 77. Akorn Macrolide Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 78. Akorn Macrolide Drugs Product
Table 79. Akorn Recent Developments/Updates
Table 80. Eli Lilly & Co. Corporation Information
Table 81. Eli Lilly & Co. Description and Business Overview
Table 82. Eli Lilly & Co. Macrolide Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 83. Eli Lilly & Co. Macrolide Drugs Product
Table 84. Eli Lilly & Co. Recent Developments/Updates
Table 85. Fresenius Kabi Corporation Information
Table 86. Fresenius Kabi Description and Business Overview
Table 87. Fresenius Kabi Macrolide Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 88. Fresenius Kabi Macrolide Drugs Product
Table 89. Fresenius Kabi Recent Developments/Updates
Table 90. Gland Pharmm Corporation Information
Table 91. Gland Pharmm Description and Business Overview
Table 92. Gland Pharmm Macrolide Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 93. Gland Pharmm Macrolide Drugs Product
Table 94. Gland Pharmm Recent Developments/Updates
Table 95. Sirolimus Corporation Information
Table 96. Sirolimus Description and Business Overview
Table 97. Sirolimus Macrolide Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 98. Sirolimus Macrolide Drugs Product
Table 99. Sirolimus Recent Developments/Updates
Table 100. Neo Química Corporation Information
Table 101. Neo Química Description and Business Overview
Table 102. Neo Química Macrolide Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 103. Neo Química Macrolide Drugs Product
Table 104. Neo Química Recent Developments/Updates
Table 105. Tacorolimus Corporation Information
Table 106. Tacorolimus Description and Business Overview
Table 107. Tacorolimus Macrolide Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 108. Tacorolimus Macrolide Drugs Product
Table 109. Tacorolimus Recent Developments/Updates
Table 110. Macrolide Pharmaceuticals Corporation Information
Table 111. Macrolide Pharmaceuticals Description and Business Overview
Table 112. Macrolide Pharmaceuticals Macrolide Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 113. Macrolide Pharmaceuticals Macrolide Drugs Product
Table 114. Macrolide Pharmaceuticals Recent Developments/Updates
Table 115. Mylan Corporation Information
Table 116. Mylan Description and Business Overview
Table 117. Mylan Macrolide Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 118. Mylan Macrolide Drugs Product
Table 119. Mylan Recent Developments/Updates
Table 120. Pfizer Corporation Information
Table 121. Pfizer Description and Business Overview
Table 122. Pfizer Macrolide Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 123. Pfizer Macrolide Drugs Product
Table 124. Pfizer Recent Developments/Updates
Table 125. Sanofi Corporation Information
Table 126. Sanofi Description and Business Overview
Table 127. Sanofi Macrolide Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 128. Sanofi Macrolide Drugs Product
Table 129. Sanofi Recent Developments/Updates
Table 130. Merck & Co. Corporation Information
Table 131. Merck & Co. Description and Business Overview
Table 132. Merck & Co. Macrolide Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 133. Merck & Co. Macrolide Drugs Product
Table 134. Merck & Co. Recent Developments/Updates
Table 135. Sandoz International Corporation Information
Table 136. Sandoz International Description and Business Overview
Table 137. Sandoz International Macrolide Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 138. Sandoz International Macrolide Drugs Product
Table 139. Sandoz International Recent Developments/Updates
Table 140. Teva Pharmaceutical Industries Corporation Information
Table 141. Teva Pharmaceutical Industries Description and Business Overview
Table 142. Teva Pharmaceutical Industries Macrolide Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 143. Teva Pharmaceutical Industries Macrolide Drugs Product
Table 144. Teva Pharmaceutical Industries Recent Developments/Updates
Table 145. WOCKHARDT Corporation Information
Table 146. WOCKHARDT Description and Business Overview
Table 147. WOCKHARDT Macrolide Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 148. WOCKHARDT Macrolide Drugs Product
Table 149. WOCKHARDT Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Macrolide Drugs Distributors List
Table 153. Macrolide Drugs Customers List
Table 154. Macrolide Drugs Market Trends
Table 155. Macrolide Drugs Market Drivers
Table 156. Macrolide Drugs Market Challenges
Table 157. Macrolide Drugs Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Macrolide Drugs
Figure 2. Global Macrolide Drugs Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Macrolide Drugs Market Share by Type in 2024 & 2034
Figure 4. 14-Membered Ring Agents Product Picture
Figure 5. 15-Membered Ring Agents Product Picture
Figure 6. 16-Membered Ring Agents Product Picture
Figure 7. Ketolides Product Picture
Figure 8. Global Macrolide Drugs Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 9. Global Macrolide Drugs Market Share by Application in 2024 & 2034
Figure 10. Hospitals
Figure 11. Clinics
Figure 12. Hospitalshospital Pharmacies
Figure 13. Retail Pharmacies
Figure 14. Online Pharmacies
Figure 15. Global Macrolide Drugs Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 16. Global Macrolide Drugs Market Size (2018-2034) & (US$ Million)
Figure 17. Global Macrolide Drugs Sales (2018-2034) & (K Units)
Figure 18. Global Macrolide Drugs Average Price (USD/Unit) & (2018-2034)
Figure 19. Macrolide Drugs Report Years Considered
Figure 20. Macrolide Drugs Sales Share by Manufacturers in 2024
Figure 21. Global Macrolide Drugs Revenue Share by Manufacturers in 2024
Figure 22. The Global 5 and 10 Largest Macrolide Drugs Players: Market Share by Revenue in 2024
Figure 23. Macrolide Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2024
Figure 24. Global Macrolide Drugs Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Figure 25. North America Macrolide Drugs Sales Market Share by Country (2018-2034)
Figure 26. North America Macrolide Drugs Revenue Market Share by Country (2018-2034)
Figure 27. U.S. Macrolide Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 28. Canada Macrolide Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 29. Europe Macrolide Drugs Sales Market Share by Country (2018-2034)
Figure 30. Europe Macrolide Drugs Revenue Market Share by Country (2018-2034)
Figure 31. Germany Macrolide Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 32. France Macrolide Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 33. U.K. Macrolide Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 34. Italy Macrolide Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 35. Russia Macrolide Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 36. Asia Pacific Macrolide Drugs Sales Market Share by Region (2018-2034)
Figure 37. Asia Pacific Macrolide Drugs Revenue Market Share by Region (2018-2034)
Figure 38. China Macrolide Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. Japan Macrolide Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. South Korea Macrolide Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. India Macrolide Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Australia Macrolide Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Taiwan Macrolide Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 44. Indonesia Macrolide Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 45. Thailand Macrolide Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 46. Malaysia Macrolide Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Philippines Macrolide Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 48. Latin America Macrolide Drugs Sales Market Share by Country (2018-2034)
Figure 49. Latin America Macrolide Drugs Revenue Market Share by Country (2018-2034)
Figure 50. Mexico Macrolide Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 51. Brazil Macrolide Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 52. Argentina Macrolide Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 53. Middle East & Africa Macrolide Drugs Sales Market Share by Country (2018-2034)
Figure 54. Middle East & Africa Macrolide Drugs Revenue Market Share by Country (2018-2034)
Figure 55. Turkey Macrolide Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 56. Saudi Arabia Macrolide Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 57. U.A.E Macrolide Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 58. Global Sales Market Share of Macrolide Drugs by Type (2018-2034)
Figure 59. Global Revenue Market Share of Macrolide Drugs by Type (2018-2034)
Figure 60. Global Macrolide Drugs Price (USD/Unit) by Type (2018-2034)
Figure 61. Global Sales Market Share of Macrolide Drugs by Application (2018-2034)
Figure 62. Global Revenue Market Share of Macrolide Drugs by Application (2018-2034)
Figure 63. Global Macrolide Drugs Price (USD/Unit) by Application (2018-2034)
Figure 64. Macrolide Drugs Value Chain
Figure 65. Macrolide Drugs Production Process
Figure 66. Channels of Distribution (Direct Vs Distribution)
Figure 67. Distributors Profiles
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed